Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
Healthcare
$20.31 -0.72%
-$0.13 today
- Market cap
- $424.93M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
52W Low $10.92High $19.79
Volume 0.12M
Average 0.10M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$28.61M
FY 2025 · Annual
Investing Cash Flow
-$95.60M
FY 2025 · Annual
Financing Cash Flow
$144.96M
FY 2025 · Annual
+219531.8% YoYCash Flow Statement
USD
Metric | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|
| Net Income | (12.66M) | (15.62M) | (40.36M) |
| Depreciation & Amortization | 1.64M | 2.2M | 3.21M |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock-Based Compensation | 451K | 754K | 996K |
| Change in Working Capital | (4.77M) | (1.04M) | 0 |
| Accounts Receivables | (2.69M) | (575K) | (3.3M) |
| Inventory | (2.41M) | (4.03M) | (7.64M) |
| Accounts Payables | (737K) | 3.12M | 3.37M |
| Other Working Capital | 1.08M | 446K | 0 |
| Other Non-Cash Items | 2.18M | (437K) | 7.54M |
| Operating Cash Flow | (13.14M) | (14.14M) | (28.61M) |
| Capital Expenditures | (2.75M) | (4.02M) | (7.41M) |
| Acquisitions (Net) | 0 | 0 | 0 |
| Purchases of Investments | (29.25M) | (5.28M) | (119.49M) |
| Sales of Investments | 3.03M | 23.26M | 31.3M |
| Other Investing Activities | 0 | 0 | 0 |
| Investing Cash Flow | (28.97M) | 13.96M | (95.6M) |
| Debt Repayment | 10M | 0 | 0 |
| Common Stock Issued | 34.88M | 66K | 39.51M |
| Common Stock Repurchased | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | (149K) | 66K | 144.96M |
| Financing Cash Flow | 44.73M | 66K | 144.96M |
| Effect of Forex Changes | 0 | 0 | 0 |
| Net Change in Cash | 2.61M | (113K) | 20.75M |
| Free Cash Flow | (15.89M) | (18.16M) | (36.02M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$40.4M
+ D&A$3.2M
+ Stock-Based Comp$996.0K
+ Deferred Tax$0
+ Working Capital$0
+ Other Non-Cash$7.5M
= Operating Cash Flow-$28.6M
- Capex-$7.4M
= Free Cash Flow-$36.0M
Analysis
FY2025 free cash flow is -$36.0M. FCF conversion is 89.2% of net income. Operating cash flow was -$28.6M, with capex of -$7.4M. The largest bridge item is Other Non-Cash at $7.5M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 2, 2026 | |
| 8-K | Current report | Oct 8, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 6, 2026 |
Does SI generate free cash flow?
Shoulder Innovations, Inc. (SI) generated -$36.02M of free cash flow in fiscal 2025.
How much operating cash flow does SI produce?
Operating cash flow was -$28.61M, before capital expenditures of $7.41M.
Continue the stock analysis
Jump to another research area for this company.